Portal de Periódicos da CAPES

Activation of Histamine H 3 -Receptors Inhibits Carrier-Mediated Norepinephrine Release During Protracted Myocardial Ischemia

1996; Lippincott Williams & Wilkins; Volume: 78; Issue: 3 Linguagem: Inglês

10.1161/01.res.78.3.475

1524-4571

Michiaki Imamura, Harry M. Lander, Roberto Levi,

Mast cells and histamine

Abstract We previously showed that prejunctional histamine H 3 -receptors downregulate norepinephrine exocytosis, which is markedly enhanced in early myocardial ischemia. In the present study, we investigated whether H 3 -receptors modulate nonexocytotic norepinephrine release during protracted myocardial ischemia. In this setting, decreased pH i in sympathetic nerve endings sequentially leads to a compensatory activation of the Na + -H + antiporter (NHE), accumulation of intracellular Na + , reversal of the neuronal uptake of norepinephrine, and thus carrier-mediated release of norepinephrine. Accordingly, norepinephrine overflow from isolated guinea pig hearts undergoing 20-minute global ischemia and 45-minute reperfusion was attenuated ≈80% by desipramine (10 nmol/L) and 70% by 5-( N -ethyl- N -isopropyl)-amiloride (EIPA, 10 μmol/L), inhibitors of norepinephrine uptake and NHE, respectively. The H 3 -receptor agonist imetit (0.1 μmol/L) decreased carrier-mediated norepinephrine release by ≈50%. This effect was blocked by the H 3 -receptor antagonist thioperamide (0.3 μmol/L), indicating that H 3 -receptor activation inhibits carrier-mediated norepinephrine release. At lower concentrations, imetit (10 nmol/L) or EIPA (3 μmol/L) did not inhibit carrier-mediated norepinephrine release. However, a 25% inhibition occurred with imetit (10 nmol/L) and EIPA (3 μmol/L) combined. This synergism suggests an association between H 3 -receptors and NHE. Conceivably, activation of H 3 -receptors may lead to inhibition of NHE. In fact, α 2 -adrenoceptor activation, which is known to stimulate NHE, enhanced norepinephrine release, whereas α 2 -adrenoceptor blockade attenuated it. Furthermore, activation of adenosine A 1 -receptors markedly attenuated norepinephrine release, whereas their inhibition potentiated it. Because norepinephrine release directly correlated with the severity of reperfusion arrhythmia and imetit reduced the incidence of ventricular fibrillation by 50%, our findings with H 3 -receptor agonists may further the development of novel pharmacological means to reduce reperfusion arrhythmias in the clinical setting.